--- title: "600998.SH (600998.SH) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/600998.SH/news.md" symbol: "600998.SH" name: "600998.SH" parent: "https://longbridge.com/en/quote/600998.SH.md" datetime: "2026-06-17T01:55:49.912Z" locales: - [en](https://longbridge.com/en/quote/600998.SH/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/600998.SH/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/600998.SH/news.md) --- # 600998.SH (600998.SH) — Related News ### [Understanding Quality and Efficiency: Let's See How Jointown Reshapes the Grand Drama](https://longbridge.com/en/news/289630873.md) *2026-06-12T14:38:00.000Z* > Jointown has reached a strategic cooperation with Hainan Medical University and others, focusing on areas such as indust ### [Jointown Pharmaceutical Group held a seminar with Hainan Medical University and Haikou International Investment Promotion Bureau](https://longbridge.com/en/news/288959811.md) *2026-06-07T12:33:52.000Z* > On June 6th, Jointown Pharmaceutical Group held a symposium with Hainan Medical University and Haikou International Inve ### [Jointown Pharmaceutical Group was awarded the "2026 ESG Exemplary Enterprise."](https://longbridge.com/en/news/288881930.md) *2026-06-05T15:01:38.000Z* > Jointown Pharmaceutical Group was awarded the "2026 ESG Model Enterprise." The company continues to increase its ESG inv ### [Jointown: The holding subsidiary's raw material drug, hydrochloride nitrosamine, has been approved for market launch](https://longbridge.com/en/news/288392136.md) *2026-06-02T08:50:13.000Z* > Jointown announced that its holding subsidiary Shandong Jingfeng has received approval from the National Medical Product ### [Essential demand? The race for "unmanned" pharmaceutical delivery](https://longbridge.com/en/news/288134368.md) *2026-05-30T03:06:28.000Z* > In 2026, the unmanned delivery in China's pharmaceutical distribution sector will accelerate. Leading companies such as ### [Jointown's subsidiary, Benzatropine Hydrochloride Tablets, has passed the consistency evaluation of generic drugs](https://longbridge.com/en/news/287611080.md) *2026-05-26T09:30:03.000Z* > Jointown's subsidiary Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd. recently received approval from the National ### [Jiren Pharmaceutical: Two promoters were canceled on the same day and personnel were intertwined during the existence period; the subsidiary and the distributor "competed in the same bidding"](https://longbridge.com/en/news/287568393.md) *2026-05-26T01:31:02.000Z* > Jiren Pharmaceutical released its review report for the first quarter of 2026, with operating revenue of 263 million yua ### [Jointown makes multiple efforts to unlock the second growth curve?](https://longbridge.com/en/news/287421281.md) *2026-05-23T06:14:37.000Z* > Jointown stated at the 2025 annual shareholders' meeting that the trend of prescription outflow is irreversible, and the ### [Jointown's subsidiary passes drug GMP compliance inspection](https://longbridge.com/en/news/285343747.md) *2026-05-06T09:07:04.000Z* > Jointown's subsidiary Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd. recently passed the GMP compliance inspection